FBXL14
Basic information
Region (hg38): 12:1565993-1594581
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FBXL14 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 14 | 14 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 14 | 1 | 1 |
Variants in FBXL14
This is a list of pathogenic ClinVar variants found in the FBXL14 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-1592914-C-T | not specified | Uncertain significance (Jun 10, 2022) | ||
12-1592922-C-T | not specified | Uncertain significance (Feb 11, 2022) | ||
12-1593045-A-G | not specified | Uncertain significance (Dec 14, 2022) | ||
12-1593069-C-T | not specified | Uncertain significance (Aug 30, 2021) | ||
12-1593165-G-C | not specified | Uncertain significance (Dec 27, 2023) | ||
12-1593235-T-C | not specified | Uncertain significance (Mar 14, 2023) | ||
12-1593304-G-A | Benign (Apr 09, 2018) | |||
12-1593384-G-C | not specified | Uncertain significance (May 30, 2024) | ||
12-1593404-C-A | not specified | Uncertain significance (Jun 22, 2023) | ||
12-1593463-G-C | not specified | Uncertain significance (May 29, 2024) | ||
12-1593620-C-G | not specified | Uncertain significance (May 27, 2022) | ||
12-1593686-G-A | Likely benign (Jan 01, 2023) | |||
12-1593796-T-C | not specified | Uncertain significance (Mar 30, 2024) | ||
12-1593907-G-C | not specified | Uncertain significance (Aug 10, 2021) | ||
12-1593927-C-T | not specified | Uncertain significance (Dec 01, 2022) | ||
12-1593988-G-A | not specified | Uncertain significance (Aug 21, 2023) | ||
12-1593988-G-T | not specified | Uncertain significance (Oct 02, 2023) | ||
12-1593993-T-C | not specified | Uncertain significance (May 30, 2024) | ||
12-1594015-C-G | not specified | Uncertain significance (Nov 20, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FBXL14 | protein_coding | protein_coding | ENST00000339235 | 2 | 28173 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.825 | 0.174 | 107747 | 0 | 1 | 107748 | 0.00000464 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.95 | 119 | 250 | 0.476 | 0.0000124 | 2682 |
Missense in Polyphen | 23 | 83.135 | 0.27666 | 961 | ||
Synonymous | -3.00 | 152 | 112 | 1.36 | 0.00000541 | 913 |
Loss of Function | 2.66 | 1 | 10.1 | 0.0988 | 4.42e-7 | 104 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000457 | 0.0000457 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Substrate-recognition component of some SCF (SKP1-CUL1- F-box protein)-type E3 ubiquitin-protein ligase complexes. The SCF(FBXL14) complex acts by mediating ubiquitination and subsequent degradation of SNAI1. {ECO:0000269|PubMed:19955572}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Neddylation
(Consensus)
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- loftool
- 0.0393
- rvis_EVS
- -0.58
- rvis_percentile_EVS
- 18.59
Haploinsufficiency Scores
- pHI
- 0.121
- hipred
- Y
- hipred_score
- 0.514
- ghis
- 0.534
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.419
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fbxl14
- Phenotype
Gene ontology
- Biological process
- protein polyubiquitination;ubiquitin-dependent protein catabolic process;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;post-translational protein modification
- Cellular component
- cytoplasm;cytosol;SCF ubiquitin ligase complex
- Molecular function
- ubiquitin-protein transferase activity;protein binding